| gemfibrozil / Generic mfg. |
NCT00000461: Harvard Atherosclerosis Reversibility Project (HARP) |
|
|
| Completed | 2 | | US | pravastatin, niacin, cholestyramine, gemfibrozil, fatty acids, omega-3 | National Heart, Lung, and Blood Institute (NHLBI) | Cardiovascular Diseases, Coronary Disease, Heart Diseases, Myocardial Ischemia | | 11/92 | | |
2011-004436-61: A study to test possible drug interactions with a new drug for treating skin cancer. |
|
|
| Completed | 2 | 8 | Europe | GSK2118436, WARFARIN, Ketoconazole, Gemfibrozil, GSK2118436, | GlaxoSmithKline Research and Development Limited, GlaxoSmithKline | Skin Cancer | | 11/12 | | |
NCT01876810: Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco Addiction |
|
|
| Completed | 2 | 28 | Canada | Gemfibrozil, Lopid, Placebo, Lactose | Centre for Addiction and Mental Health | Nicotine Dependence | 02/16 | 02/16 | | |
| Completed | 2 | 16 | US | Gemfibrozil, Lopid, smoking cessation counseling | University of Texas Southwestern Medical Center | Smoking Cessation | 12/16 | 12/16 | | |
NCT03539432: Exploration of Gemfibrozil as a Treatment for AUD |
|
|
| Terminated | 2 | 3 | US | Gemfibrozil 600 MG, Placebo oral capsule | The Mind Research Network | Alcohol Use Disorder | 12/18 | 12/18 | | |
NCT05931484: Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients. |
|
|
| Not yet recruiting | 2 | 32 | NA | Gemfibrozil, Placebo, Placebo to match Gemfibrozil solution | Forest Hills Lab | Parkinson Disease | 12/24 | 12/24 | | |
| Recruiting | 1/2 | 60 | US, Canada | Nicotine dependence/Gemfibrozil | National Institute on Drug Abuse (NIDA) | Nicotine Dependence | 06/14 | 06/14 | | |
